文献速递消化道肿瘤与早癌肝病

肝细胞癌中自然杀伤细胞NKp30介导功能缺陷及NCR3剪接变异体改变

Deficient Natural Killer Cell NKp30-Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma.
PubMed 文献 · Hepatology · 2019-02-14

研究探讨了活化性自然细胞毒性受体NKp30及其主要配体B7-H6在肝细胞癌(HCC)患者中的作用。外周血NK细胞表型偏向缺陷/耗竭免疫特征,NKp30阳性NK细胞中NCR3免疫刺激剪接变异体表达降低而抑制性变异体表达升高,导致NKp30介导功能缺陷;肿瘤浸润淋巴细胞呈现抑制性NKp30亚型谱,B7-H6在HCC组织中表达降低而可溶性形式升高,尤其在晚期或较大结节患者中。结论认为这些发现支持NKp30及其主要配体在HCC发生和演变中的作用。

要点

  • HCC患者外周血NK细胞NKp30表达频率降低,表型偏向缺陷/耗竭。
  • 晚期肿瘤患者NKp30阳性NK细胞NCR3免疫刺激剪接变异体表达降低、抑制性变异体升高。
  • HCC组织中B7-H6表达降低,可溶性B7-H6在晚期或较大结节患者中升高。

核心结论

  • 这些发现提供证据支持NKp30及其主要配体在肝细胞癌发生和演变中发挥作用。

研究设计与样本

  • 研究纳入肝细胞癌患者,检测外周血NK细胞表型、NCR3剪接变异体表达、肿瘤浸润淋巴细胞NKp30亚型及B7-H6表达。

主要发现

  • 外周血NK细胞表型偏向缺陷/耗竭免疫特征,表达NKp30和自然杀伤组2成员D的细胞频率降低,表达T细胞免疫球蛋白和黏蛋白域包含3的细胞比例增加。
  • 晚期肿瘤患者NKp30阳性NK细胞中NCR3免疫刺激剪接变异体表达降低、抑制性变异体表达升高,导致NKp30介导功能缺陷。
  • 肿瘤浸润淋巴细胞呈现以抑制性NKp30亚型为主,与NKp30介导功能降低一致。
  • 肿瘤组织与周围非肿瘤组织之间细胞因子环境存在显著差异,可能进一步影响NKp30功能。
  • 表达B7-H6的HCC细胞暴露可显著下调NK细胞NKp30,小干扰RNA介导的敲低可阻止该下调,提示该配体在抑制NKp30介导应答中的作用;HCC组织中B7-H6表达降低,同时HCC患者中可溶性B7-H6升高,尤其在晚期或较大结节患者中。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The activating natural cytotoxicity receptor NKp30 is critical for natural killer (NK) cell function and tumor immune surveillance. The natural cytotoxicity receptor-3 (NCR3) gene is transcribed into several splice variants whose physiological relevance is still incompletely understood. In this study, we investigated the role of NKp30 and its major ligand B7 homolog 6 (B7-H6) in patients with hepatocellular carcinoma (HCC). Peripheral blood NK cell phenotype was skewed toward a defective/exhausted immune profile with decreased frequencies of cells expressing NKp30 and natural killer group 2, member D and an increased proportion of cells expressing T-cell immunoglobulin and mucin-domain containing-3. Moreover, NKp30-positive NK cells had a reduced expression of NCR3 immunostimulatory splice variants and an increased expression of the inhibitory variant in patients with advanced tumor, resulting in deficient NKp30-mediated functionality. Tumor-infiltrating lymphocytes showed a prevalent inhibitory NKp30 isoform profile, consistent with decreased NKp30-mediated function. Of note, there were significant differences in the cytokine milieu between the neoplastic and the surrounding non-neoplastic tissue, which may have further influenced NKp30 function. Exposure of NK cells to B7-H6-expressing HCC cells significantly down-modulated NKp30, that was prevented by small interfering RNA-mediated knockdown, suggesting a role for this ligand in inhibiting NKp30-mediated responses. Interestingly, B7-H6 expression was reduced in HCC tissue and simultaneously augmented as a soluble form in HCC patients, particularly those with advanced staging or larger nodule size. Conclusion: These findings provide evidence in support of a role of NKp30 and its major ligand in HCC development and evolution.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Mantovani S, Oliviero B, Lombardi A, et al. Deficient Natural Killer Cell NKp30-Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma. Hepatology. 2019. PMID: 30153337. doi:10.1002/hep.30235

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。